Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

RWJ-56110: design, synthesis and characterization of new peptidomimetic PAR-1 antagonist

Oct. 29, 1999

Anticoagulants remain focus of research at Warner-Lambert

Oct. 29, 1999

Warner-Lambert discloses another series of anticoagulants

Oct. 28, 1999

Warner-Lambert patents new anticoagulants with quinolinone structure

Oct. 27, 1999

First approval obtained for bivalirudin

Oct. 26, 1999

LMW heparin to be marketed in U.K. and Ireland by ICN

Oct. 26, 1999

New anticoagulants in the pipeline at DuPont

Oct. 25, 1999

Essex Pharma launches clot buster in Germany

Oct. 20, 1999

Merck's new fibrinogen receptor antagonists disclosed in recent patent

Oct. 14, 1999

BCH-2763 shows antithrombotic activity in canine model of DVT

Oct. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...